Snapshot
- Ticker: AVAV (NASDAQ)
- Bucket: Power & Physical Infrastructure
- Q1 2026 position: 161,675 shares, $29.6 M, 0.59% of 13F — new position this quarter
- HQ: Arlington, Virginia
- What it does: Defense-tech prime for small drones, Switchblade loitering munitions, counter-UAS, directed energy, and space systems.
Business Overview
AeroVironment built its franchise on small uncrewed aircraft (Puma, JUMP 20) and the Switchblade loitering-munition family that became a signature weapon of the Ukraine war. Fiscal 2025 (ended April 30, 2025) revenue was 43.6 M. Then the company transformed itself: the all-stock BlueHalo merger closed May 1, 2025, roughly doubling scale and adding space, cyber, counter-UAS, and directed-energy lines. The combined company now reports two segments — Autonomous Systems and Space, Cyber & Directed Energy.
Fiscal 2026 shows the integration in full: Q1 revenue 235.2 M), Q2 a record 408.0 M (+143%). Q3 also brought the merger’s first scar — a **156.6 M net loss and gross margin compression to 24% (from 38% a year earlier). Demand signals remain strong: funded backlog of 726.6 M at fiscal year-end), nine-month bookings of 1.85–1.95 B revenue with $265–285 M adjusted EBITDA.
Why Atreides Owns It
This is one of two defense-tech autonomy names (with Axon) in the Power & Physical Infrastructure bucket — Baker’s framework extended from data-center watts and wafers to AI in the physical world. Attritable drones and loitering munitions are the clearest battlefield expression of cheap autonomy riding consumer-electronics cost curves, and AVAV is the only pure-play, scaled, US-listed way to own that. The post-BlueHalo company also touches two other Atreides preoccupations: counter-UAS (the demand signal Axon’s 300%-growth counter-drone line confirms from the civilian side) and space communications, adjacent to Baker’s public argument that “data centers in space” matter over the next 3–4 years. At 0.59% of the book it is a starter position, initiated in a quarter when the stock had de-rated on the goodwill impairment and guidance cut — consistent with Atreides’ pattern of entering controversial names into weakness.
Position History
| Quarter | Type | Shares/Notional | Value | % of 13F |
|---|---|---|---|---|
| Q4 2024 | — | not held | — | — |
| Q1 2025 | — | not held | — | — |
| Q2 2025 | — | not held | — | — |
| Q3 2025 | — | not held | — | — |
| Q4 2025 | — | not held | — | — |
| Q1 2026 | Common | 161,675 | $29,594,609 | 0.59% |
A clean new entry in Q1 2026 with no prior history in the filing window — Atreides had no disclosed defense-prime exposure before this quarter. Sizing is small enough to be a toe-hold; whether it gets built like Ciena and Micron were, or cycled out like many sub-1% starters, is the thing to watch in Q2 2026.
Risks
- Program risk is real, not theoretical: the BADGER stop-work order already forced a $151.3 M goodwill write-down; DoD procurement is lumpy and politically exposed.
- BlueHalo integration: gross margin fell from 38% to 24% year-over-year in Q3 FY2026; the merged company guides to a GAAP net loss of $(218)–(201) M for FY2026.
- Ukraine demand normalization: Switchblade and small-UAS orders surged with the war; a ceasefire or shift in US aid would hit the highest-visibility product line.
- Competition from defense-tech insurgents: Anduril and venture-backed drone makers attack the same attritable-autonomy budgets with software-first positioning.
- Valuation vs. GAAP losses: the stock prices in the $1.85–1.95 B revenue ramp and a clean FY2027; further impairments or guidance cuts would compound de-rating.